September 20, 2023
InBios Awarded New Contract to Supply COVID-19 Tests
By info@inbios.com|2023-10-25T19:19:51+00:00September 25th, 2023|InBios In the News|
InBios Awarded New Contract to Supply COVID-19 Tests
By info@inbios.com|2023-10-25T19:10:06+00:00March 1st, 2023|InBios In the News|
FDA Grants First Marketing Rights for Anthrax Point-of-Care Test to InBios
By info@inbios.com|2023-10-25T19:20:12+00:00November 22nd, 2022|InBios In the News|
InBios Awarded Funding for Lyme Disease Diagnostic from HHS, Cohen Foundation
By info@inbios.com|2023-10-25T19:46:28+00:00August 29th, 2022|InBios In the News|
Rapid Antigen Tests Accurately Detect COVID Variants
By info@inbios.com|2023-10-25T19:46:51+00:00August 29th, 2022|InBios In the News|
Antigen Tests Accurately Detect COVID-19 Variants in Study
By info@inbios.com|2023-10-25T19:47:33+00:00May 18th, 2022|Conferences|
AACC Annual Meeting, July 24-28, Chicago, IL
By info@inbios.com|2023-10-25T19:47:51+00:00January 19th, 2022|InBios In the News|
InBios Featured on NBC COVID-19 Update
By info@inbios.com|2023-10-25T19:48:16+00:00January 3rd, 2022|InBios In the News|
Manufacturers Rush to Ramp Up Rapid COVID Test Production
By info@inbios.com|2023-10-25T19:48:32+00:00January 3rd, 2022|InBios In the News|
Companies Produce 'Tens of Millions' More Rapid COVID Tests
By info@inbios.com|2023-10-25T19:48:50+00:00January 3rd, 2022|InBios In the News|
U.S. Testing Struggles to Keep Up with Omicron